{"DataElement":{"publicId":"2775235","version":"1","preferredName":"AIDS Malignancy Consortium Patient Exclusion Clinical Trial Eligibility Criteria 059 Type","preferredDefinition":"the type of element of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial of a person who receives medical attention, care, or treatment in a clinical trials cooperative group supported by NCI.","longName":"AMC_PT_E_CTEC_059_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2518234","version":"1","preferredName":"AIDS Malignancy Consortium Patient Exclusion Clinical Trial Eligibility Criteria","preferredDefinition":"information relating to the elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial of a person who receives medical attention, care, or treatment in a clinical trials cooperative group supported by the NCI.","longName":"AMC_PT_EXCLU_CTEC","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2518228","version":"1","preferredName":"AIDS Malignancy Consortium Patient","preferredDefinition":"Established in 1995 to carry out Phase I and II studies of innovative therapies for AIDS malignancies.:A person who requires medical care.","longName":"C19707:C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"AIDS Malignancy Consortium","conceptCode":"C19707","definition":"Established in 1995 to carry out Phase I and II studies of innovative therapies for AIDS malignancies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CC96D39-08C6-6793-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-06","modifiedBy":"ONEDATA","dateModified":"2006-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2518232","version":"1","preferredName":"Exclusion Clinical Trial Eligibility Criteria","preferredDefinition":"Exclusion; the act of restricting entrance or barring from participation.:Elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.","longName":"C25370:C16112","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Exclusion Criteria","conceptCode":"C25370","definition":"Medical and/or social characteristics that prevent a subject from being allowed to participate in a clinical study, as outlined in the study protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CC88111-1844-69E1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-06","modifiedBy":"ONEDATA","dateModified":"2006-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CC88111-1855-69E1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2775236","version":"1","preferredName":"059 Exclusion Clinical Trial Eligibility Criteria Type","preferredDefinition":"the type of clinical trial eligibility exclusion criteria for an AIDS Malignancy Consortium 059 protocol.","longName":"059_EXCL_CTEC_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"255","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Does the participant have concurrent, acute, active opportunistic infection other than oral thrush or genital herpes within 14 days of enrollment","valueDescription":"Does the participant have concurrent, acute, active opportunistic infection other than oral thrush or genital herpes within 14 days of enrollment","ValueMeaning":{"publicId":"2775241","version":"1","preferredName":"Does the participant have concurrent, acute, active opportunistic infection other than oral thrush or genital herpes within 14 days of enrollment","longName":"2775241","preferredDefinition":"Does the participant have concurrent, acute, active opportunistic infection other than oral thrush or genital herpes within 14 days of enrollment","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54E93D39-D949-0AA2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"54E92C8E-D380-0B1A-E044-0003BA3F9857","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"ONEDATA","dateModified":"2008-08-20","deletedIndicator":"No"},{"value":"Does the participant have symptomatic visceral KS requiring cytotoxic therapy","valueDescription":"Does the participant have symptomatic visceral KS requiring cytotoxic therapy","ValueMeaning":{"publicId":"2775240","version":"1","preferredName":"Does the participant have symptomatic visceral KS requiring cytotoxic therapy","longName":"2775240","preferredDefinition":"Does the participant have symptomatic visceral KS requiring cytotoxic therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54E93B68-E4C0-0AA7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"54E92C8E-D392-0B1A-E044-0003BA3F9857","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"ONEDATA","dateModified":"2008-08-20","deletedIndicator":"No"},{"value":"Does the participant have concurrent neoplasia requiring cytotoxic therapy","valueDescription":"Does the participant have concurrent neoplasia requiring cytotoxic therapy","ValueMeaning":{"publicId":"2685803","version":"1","preferredName":"Does the participant have concurrent neoplasia requiring cytotoxic therapy","longName":"2685803","preferredDefinition":"Does the participant have concurrent neoplasia requiring cytotoxic therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3BC12A4D-92A8-0925-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-10-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"54E92C8E-D39E-0B1A-E044-0003BA3F9857","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"ONEDATA","dateModified":"2008-08-20","deletedIndicator":"No"},{"value":"Has the participant had acute treatment for an (other than oral thrush or genital herpes) or other serious medical illness within 14 days prior to enrollment","valueDescription":"Has the participant had acute treatment for an (other than oral thrush or genital herpes) or other serious medical illness within 14 days prior to enrollment","ValueMeaning":{"publicId":"2775238","version":"1","preferredName":"Has the participant had acute treatment for an (other than oral thrush or genital herpes) or other serious medical illness within 14 days prior to enrollment","longName":"2775238","preferredDefinition":"Has the participant had acute treatment for an (other than oral thrush or genital herpes) or other serious medical illness within 14 days prior to enrollment","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54E934B3-9BE4-0DA7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"54E92C8E-D3AF-0B1A-E044-0003BA3F9857","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"ONEDATA","dateModified":"2008-08-20","deletedIndicator":"No"},{"value":"Has the participant had antineoplastic treatment for KS (including chemotherapy, radiation therapy, biological therapy, or investigational therapy) within 4 weeks of study entry","valueDescription":"Has the participant had antineoplastic treatment for KS (including chemotherapy, radiation therapy, biological therapy, or investigational therapy) within 4 weeks of study entry","ValueMeaning":{"publicId":"2775237","version":"1","preferredName":"Has the participant had antineoplastic treatment for KS (including chemotherapy, radiation therapy, biological therapy, or investigational therapy) within 4 weeks of study entry","longName":"2775237","preferredDefinition":"Has the participant had antineoplastic treatment for KS (including chemotherapy, radiation therapy, biological therapy, or investigational therapy) within 4 weeks of study entry","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54E931C2-07BE-0C69-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"54E92C8E-D3C1-0B1A-E044-0003BA3F9857","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"ONEDATA","dateModified":"2008-08-20","deletedIndicator":"No"},{"value":"Has the participant had previous local therapy of any KS indicator lesion within 60 days prior to enrollment unless the lesion has clearly progressed since treatment","valueDescription":"Has the participant had previous local therapy of any KS indicator lesion within 60 days prior to enrollment unless the lesion has clearly progressed since treatment","ValueMeaning":{"publicId":"2775246","version":"1","preferredName":"Has the participant had previous local therapy of any KS indicator lesion within 60 days prior to enrollment unless the lesion has clearly progressed since treatment","longName":"2775246","preferredDefinition":"Has the participant had previous local therapy of any KS indicator lesion within 60 days prior to enrollment unless the lesion has clearly progressed since treatment","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54E945EF-D81E-0B3E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"54E93B68-E4D7-0AA7-E044-0003BA3F9857","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"ONEDATA","dateModified":"2008-08-20","deletedIndicator":"No"},{"value":"Has the participant used any investigational drug or treatment (excluding antiretroviral therapy or agents available on a treatment IND) within 28 days prior to enrollment","valueDescription":"Has the participant used any investigational drug or treatment (excluding antiretroviral therapy or agents available on a treatment IND) within 28 days prior to enrollment","ValueMeaning":{"publicId":"2775245","version":"1","preferredName":"Has the participant used any investigational drug or treatment (excluding antiretroviral therapy or agents available on a treatment IND) within 28 days prior to enrollment","longName":"2775245","preferredDefinition":"Has the participant used any investigational drug or treatment (excluding antiretroviral therapy or agents available on a treatment IND) within 28 days prior to enrollment","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54E9387E-A3AE-094D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"54E93B68-E4E9-0AA7-E044-0003BA3F9857","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"ONEDATA","dateModified":"2008-08-20","deletedIndicator":"No"},{"value":"Does the participant have a history of any of the following: myocardial infarction, severe/unstable angina, coronary/peripheral artery bypass graft, symptomatic congestive heart failure, cerebral vascular accident","valueDescription":"Does the participant have a history of any of the following: myocardial infarction, severe/unstable angina, coronary/peripheral artery bypass graft, symptomatic congestive heart failure, cerebral vascular accident","ValueMeaning":{"publicId":"2775244","version":"1","preferredName":"Does the participant have a history of any of the following: myocardial infarction, severe/unstable angina, coronary/peripheral artery bypass graft, symptomatic congestive heart failure, cerebral vascular accident","longName":"2775244","preferredDefinition":"Does the participant have a history of any of the following: myocardial infarction, severe/unstable angina, coronary/peripheral artery bypass graft, symptomatic congestive heart failure, cerebral vascular accident","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54E945EF-D80E-0B3E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"54E93B68-E4FB-0AA7-E044-0003BA3F9857","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"ONEDATA","dateModified":"2008-08-20","deletedIndicator":"No"},{"value":"Does the participant have a history of any of the following: transient ischemic attack, pulmonary embolism, deep vein thrombosis, or other significant thromboembolic event","valueDescription":"Does the participant have a history of any of the following: transient ischemic attack, pulmonary embolism, deep vein thrombosis, or other significant thromboembolic event","ValueMeaning":{"publicId":"2775243","version":"1","preferredName":"Does the participant have a history of any of the following: transient ischemic attack, pulmonary embolism, deep vein thrombosis, or other significant thromboembolic event","longName":"2775243","preferredDefinition":"Does the participant have a history of any of the following: transient ischemic attack, pulmonary embolism, deep vein thrombosis, or other significant thromboembolic event","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54E943C3-B8AA-0B42-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"54E93B68-E50D-0AA7-E044-0003BA3F9857","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"ONEDATA","dateModified":"2008-08-20","deletedIndicator":"No"},{"value":"Does the participant have a known coagulopathy or bleeding diathesis","valueDescription":"Does the participant have a known coagulopathy or bleeding diathesis","ValueMeaning":{"publicId":"2775242","version":"1","preferredName":"Does the participant have a known coagulopathy or bleeding diathesis","longName":"2775242","preferredDefinition":"Does the participant have a known coagulopathy or bleeding diathesis","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54E92C8E-D3CC-0B1A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"54E93B68-E51F-0AA7-E044-0003BA3F9857","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"ONEDATA","dateModified":"2008-08-20","deletedIndicator":"No"},{"value":"Does the participant have any history of the following: central nervous system, pulmonary, gastrointestinal, or urinary bleeding","valueDescription":"Does the participant have any history of the following: central nervous system, pulmonary, gastrointestinal, or urinary bleeding","ValueMeaning":{"publicId":"2775251","version":"1","preferredName":"Does the participant have any history of the following: central nervous system, pulmonary, gastrointestinal, or urinary bleeding","longName":"2775251","preferredDefinition":"Does the participant have any history of the following: central nervous system, pulmonary, gastrointestinal, or urinary bleeding","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54E931C2-07CE-0C69-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"54E956B8-3C98-0AA0-E044-0003BA3F9857","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"ONEDATA","dateModified":"2008-08-20","deletedIndicator":"No"},{"value":"Does the participant have a resting systolic blood pressure >160 mmHg or diastolic blood pressure >100 mmHg","valueDescription":"Does the participant have a resting systolic blood pressure >160 mmHg or diastolic blood pressure >100 mmHg","ValueMeaning":{"publicId":"2775250","version":"1","preferredName":"Does the participant have a resting systolic blood pressure >160 mmHg or diastolic blood pressure >100 mmHg","longName":"2775250","preferredDefinition":"Does the participant have a resting systolic blood pressure >160 mmHg or diastolic blood pressure >100 mmHg","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54E93D39-D959-0AA2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"54E956B8-3CAA-0AA0-E044-0003BA3F9857","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"ONEDATA","dateModified":"2008-08-20","deletedIndicator":"No"},{"value":"If the participant is female, is she pregnant or breast-feeding","valueDescription":"If the participant is female, is she pregnant or breast-feeding","ValueMeaning":{"publicId":"2649481","version":"1","preferredName":"If the participant is female, is she pregnant or breast-feeding","longName":"2649481","preferredDefinition":"If the participant is female, is she pregnant or breast-feeding","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"32655A77-934F-3C34-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"54E956B8-3CB6-0AA0-E044-0003BA3F9857","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"ONEDATA","dateModified":"2008-08-20","deletedIndicator":"No"},{"value":"Does the participant have a prior or ongoing clinically significant illness, medical condition, surgical history, physical finding, ECG finding, or laboratory abnormality","valueDescription":"Does the participant have a prior or ongoing clinically significant illness, medical condition, surgical history, physical finding, ECG finding, or laboratory abnormality","ValueMeaning":{"publicId":"2775249","version":"1","preferredName":"Does the participant have a prior or ongoing clinically significant illness, medical condition, surgical history, physical finding, ECG finding, or laboratory abnormality","longName":"2775249","preferredDefinition":"Does the participant have a prior or ongoing clinically significant illness, medical condition, surgical history, physical finding, ECG finding, or laboratory abnormality","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54E95185-4581-0B16-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"54E956B8-3CC7-0AA0-E044-0003BA3F9857","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"ONEDATA","dateModified":"2008-08-20","deletedIndicator":"No"},{"value":"In the investigator?s opinion, could these factors affect the safety of the subject; alter the absorption of the study drug; or impair the assessment of study results","valueDescription":"In the investigator's opinion, could these factors affect the safety of the subject; alter the absorption of the study drug; or impair the assessment of study results","ValueMeaning":{"publicId":"2775248","version":"1","preferredName":"In the investigator's opinion, could these factors affect the safety of the subject; alter the absorption of the study drug; or impair the assessment of study results","longName":"2775248","preferredDefinition":"In the investigator's opinion, could these factors affect the safety of the subject; alter the absorption of the study drug; or impair the assessment of study results","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54E943C3-B8BA-0B42-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"54E956B8-3CD9-0AA0-E044-0003BA3F9857","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"ONEDATA","dateModified":"2008-08-20","deletedIndicator":"No"},{"value":"Has the participant had major surgery within 30 days prior to enrollment, the presence of unhealed surgical wounds at the time of enrollment or anticipated need for surgical procedures during the period of study participation","valueDescription":"Has the participant had major surgery within 30 days prior to enrollment, the presence of unhealed surgical wounds at the time of enrollment or anticipated need for surgical procedures during the period of study participation","ValueMeaning":{"publicId":"2775254","version":"1","preferredName":"Has the participant had major surgery within 30 days prior to enrollment, the presence of unhealed surgical wounds at the time of enrollment or anticipated need for surgical procedures during the period of study participation","longName":"2775254","preferredDefinition":"Has the participant had major surgery within 30 days prior to enrollment, the presence of unhealed surgical wounds at the time of enrollment or anticipated need for surgical procedures during the period of study participation","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54E93D39-D969-0AA2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"54E95185-4598-0B16-E044-0003BA3F9857","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"ONEDATA","dateModified":"2008-08-20","deletedIndicator":"No"},{"value":"Is the participant on ongoing systemic corticosteroid treatment, other than replacement doses","valueDescription":"Is the participant on ongoing systemic corticosteroid treatment, other than replacement doses","ValueMeaning":{"publicId":"2775253","version":"1","preferredName":"Is the participant on ongoing systemic corticosteroid treatment, other than replacement doses","longName":"2775253","preferredDefinition":"Is the participant on ongoing systemic corticosteroid treatment, other than replacement doses","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54E95D74-8FA8-0B5B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"54E95185-45AA-0B16-E044-0003BA3F9857","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"ONEDATA","dateModified":"2008-08-20","deletedIndicator":"No"},{"value":"Is there ongoing use of anticoagulant therapy, including coumadin, heparin or antiplatelet drugs","valueDescription":"Is there ongoing use of anticoagulant therapy, including coumadin, heparin or antiplatelet drugs","ValueMeaning":{"publicId":"2775252","version":"1","preferredName":"Is there ongoing use of anticoagulant therapy, including coumadin, heparin or antiplatelet drugs","longName":"2775252","preferredDefinition":"Is there ongoing use of anticoagulant therapy, including coumadin, heparin or antiplatelet drugs","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54E956B8-3CE4-0AA0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"54E95185-45BC-0B16-E044-0003BA3F9857","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"ONEDATA","dateModified":"2008-08-20","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2177853","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"Type","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C16D625D-02B6-1907-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-07-09","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-07-09","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"54E92A1B-CE21-0A9C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"SHIDED","dateModified":"2011-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Exclusion Criteria","type":"Preferred Question Text","description":"Exclusion Criteria","url":null,"context":"CTEP"}],"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"54E91F5B-5369-0AED-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-08-20","modifiedBy":"CAMPBELB","dateModified":"2011-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}